DAVID LONARD to Enzyme Inhibitors
This is a "connection" page, showing publications DAVID LONARD has written about Enzyme Inhibitors.
Connection Strength
0.157
-
Targeting NSD2-mediated SRC-3 liquid-liquid phase separation sensitizes bortezomib treatment in multiple myeloma. Nat Commun. 2021 02 15; 12(1):1022.
Score: 0.145
-
Inhibition of the 26S proteasome blocks progesterone receptor-dependent transcription through failed recruitment of RNA polymerase II. J Steroid Biochem Mol Biol. 2005 Mar; 94(4):337-46.
Score: 0.012